Xi Zhan

Xi Zhan

Auto-generated profile, based on publicly available information

Xi Zhan

Beijing Institute of Respiratory Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
XZXi Zhan
Xi Zhan
WYWei Yan
Wei Yan
YWYing Wang
Ying Wang
QLQing Li
Qing Li
XSXuhua Shi
Xuhua Shi
QYQiao Ye
Qiao Ye
Background: Anti-synthetase syndrome (ASSD) is a chronic autoimmune condition characterized by antibodies directed against an aminoacycl transfer RNA synthetase (ARS) along with a group of clinical features including the classical clinical triad: inflammatory myopathy, arthritis, and interstitial lung disease (ILD). ASSD is highly heterogenous due to different organ involvement, and ILD is the main cause of mortality and function loss, which presents as different patterns when diagnosed. We designed this retrospective cohort to describe the clinical features and disease behaviour of ASSD associated ILD. Methods: Data of 108 cases of ASSD associated ILD were retrospectively collected in Beijing Chaoyang Hospital from December 2017 to March 2019. Data were obtained from the Electronic Medical Record system. Patients were divided into 5 groups according to distinct aminoacyl tRNA synthetase (ARS) antibodies. Results: Overall, 108 consecutive patients were recruited. 33 were JO-1 positive, 30 were PL-7 positive, 23 were EJ positive, 13 were PL-12 positive and 9 were OJ positive. The JO-1 (+) group had a significant higher rate of mechanic’s hand (57.6%) than other 4 groups. Polymyositis/dermatomyositis (PM/DM) was diagnosed in 25 (23.1%) patients and no difference was observed among the 5 groups. The PL-7 (+) group had a higher frequency of UIP pattern (13.3%) than the other 4 groups but the difference was not significant, and the EJ (+) group had the most frequent OP pattern (78.2%), which was significantly higher than the PL-7 (+) (P < 0.001) and PL-12 (+) groups (P = 0.025). The median follow-up time was 10.7 months, during which no patients died. All received prednisone treatment, with or without immunosuppressants. At the 6-month follow-up, 96.3% of all patients (104/108) had a positive response to therapy, the JO-1 (+) and EJ (+) groups had a significantly higher improvement of forced vital capacity than the other 3 groups (P < 0.05), and the PL-7 group had the lowest FVC improvement (P < 0.05). The JO-1 (+) group and EJ (+) group had significantly higher anti-Ro-52 positive occurrence than the other 3 groups (P < 0.05). Conclusion: Anti PL-7 antibody had the same frequency as anti-JO-1 in ASSD-ILD, in which the ILD pattern was different with distinct anti-ARS antibodies. Most ASSD-ILD had a positive response to steroid therapies, with or without immunosuppressants. The PL-7 (+) group had the highest occurrence of UIP pattern, and a significantly lower response to therapy.

27 November 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
SYShuqiao Yang
Shuqiao Yang
DCDandan Chai
Dandan Chai
YLYihua Li
Yihua Li
YWYuanying Wang
Yuanying Wang
XZXi Zhan
Xi Zhan
QYQiao Ye
Qiao Ye

20 September 2018 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
CZChun-Ming Zheng
Chun-Ming Zheng
XZXi Zhan
Xi Zhan
YYYuan-Hua Yang
Yuan-Hua Yang
TJTao Jiang
Tao Jiang
QYQiao Ye
Qiao Ye
YLYong Lu
Yong Lu
Background: Idiopathic pulmonary fibrosis (IPF) is an age-related and progressive interstitial lung disease. Up to 20% of cases of IPF cluster in families, genetic factors contribute significantly to the pathogenesis of the disease. This study aimed to explore the association between rare genetic variants and IPF in Chinese Han families. Methods: A Han family, comprising three IPF patients and five unaffected their first-degree relatives, and 100 ethnically matched control individuals from North China were enrolled in this study. Peripheral blood was collected, and genomic DNA was extracted. To elucidate if rare genetic variants are associated with the familial IPF, we performed whole-exome sequencing of affected members from a Chinese Han IPF family. Candidate rare variants were then confirmed by Sanger sequencing. Results: We identified a potentially damaging rare variant-a heterozygous mutation c.2146G>A in exon 6 of the gene encoding for telomerase reverse transcriptase (TERT), which results in an amino acid substitution (p.Ala716Thr). We confirmed the missense mutation by Sanger sequencing in all the affected family members but did not detect this mutation in 100 ethnically matched healthy controls. Patients carried this mutation were characterized by the frequently acute exacerbation of IPF phenotype, with poor prognosis. The mean time to death was 2.8 years after diagnosis. Conclusion: Using next-generation sequencing technology in familial IPF patients, we identified the heterozygous rare variant in TERT gene, and strengthened the importance of genetic variants in telomere-related pathogenesis in Chinese IPF patients. TERT 基因的罕见错义突变与中国汉族家族特发性肺纤维化相关 摘要 背景:特发性肺纤维化(IPF)是一种和年龄相关的进展性间质性肺疾病。多达20%的IPF患者呈现家族聚集性,遗传因素在IPF发病过程中起到重要作用。本研究的目的是探寻罕见遗传变异与中国汉族家族特发性肺纤维化的相关性。 方法:收集了一个中国汉族IPF家系,包含3例IPF患者和5名非患病一级亲属。同时收集了100名与上述IPF患者性别、年龄相匹配的非患病的中国北方汉族人作为对照。所有受试者采集外周血提取DNA。为了研究罕见遗传变异是否与家族性IPF相关,我们对该家系的IPF患者进行了全外显子组测序。候选罕见变异位点采用Sanger测序证实。 结果:我们在该家系发现了一个可能致病的罕见变异位点,该杂合变异c.2146G>A位于端粒逆转录酶基因(TERT)的第6外显子区,导致p.Ala716Thr错义突变。Sanger测序在家系中证实了该变异,在100名对照受试者中未检测到该变异。携带该突变的IPF患者表现为频繁急性加重表型,预后差,诊断后平均生存时间为2.8年。 结论:通过对家族性IPF进行新一代测序技术分析,我们发现了与疾病相关的TERT基因的罕见变异,在中国IPF患者中进一步证实了遗传变异在端粒相关致病机制中的重要作用。

17 May 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
DWDong Wang
Dong Wang
LGLujia Guan
Lujia Guan
QYQian Yin
Qian Yin
XHXiaoxia Hou
Xiaoxia Hou
XZXi Zhan
Xi Zhan
ZTZhao-Hui Tong
Zhao-Hui Tong
Background: Non-human immunodeficiency virus (HIV) immunocompromised patients with Pneumocystis jirovecii pneumonia (PJP) face rapid progression and high mortality, necessitating a predictive model to identify patients at risk of adverse clinical outcomes for timely interventions and improved stratification. Methods: Patients admitted between January 2011 and June 2024 at Beijing Chao-Yang Hospital were retrospectively analyzed. Collected data included patients’ demographics, smoking status, comorbidities, immunosuppressive diseases, blood laboratory tests, in-hospital treatment, and adverse clinical outcomes. Predictor selection was performed using the least absolute shrinkage and selection operator (LASSO) and logistic regression, with selected features incorporated into a nomogram. Internal validation was conducted using a 500-bootstrap resampling method to ensure model robustness. Model performance was assessed via the area under the receiver operating curve (AUC), calibration plots, decision curve analysis (DCA), and clinical impact curve (CIC). Results: Among the 431 patients, 243 (56.4%) experienced adverse clinical outcomes. LASSO regression screened 21 variables, selecting 9 predictors with non-zero coefficients through 10-fold cross-validation at lambda.1se = 0.0453 (log(lambda.1se) = -3.092). Multivariate logistic regression identified 7 independent risk factors for adverse clinical outcomes: smoking status, cytomegalovirus infection, diabetes, neutrophil-lymphocyte ratio (NLR), lactate dehydrogenase (LDH), PaO2/FiO2 (PFR), and lymphocyte subset. These factors were incorporated into a nomogram, achieving an AUC of 0.89 (95% CI: 0.86–0.92), with the Hosmer–Lemeshow test (p = 0.134) and calibration curves showing strong agreement between predicted and observed outcomes. Internal validation via 500-bootstrap resampling yielded a bias-corrected AUC of 0.83 (95% CI: 0.80–0.86). DCA demonstrated strong clinical decision-making utility, while the CIC confirmed its practical reliability. Conclusions: Regression analysis identified smoking status, CMV infection, diabetes, NLR, LDH, PFR, and lymphocyte subset as independent risk factors for adverse clinical outcomes in non-HIV PJP patients. The predictive model constructed from these factors exhibited robust accuracy and reliability.

23 June 2020 in Archives of Pulmonology and Respiratory Care
Verified
Journal Article
Open access
PDF file
XZXi Zhan
Xi Zhan
ZZZhigang Zhao
Zhigang Zhao
TLTing Li
Ting Li
The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) has led to a pandemic situation.

13 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
XZXi Zhan
Xi Zhan
YWYan Wei
Yan Wei
WYWang Ying
Wang Ying
LQLi Qing
Li Qing
SXShi Xuhua
Shi Xuhua
YQYe Qiao
Ye Qiao
BackgroundAnti-synthetase syndrome (ASSD) is a chronic autoimmune condition characterized by antibodies directed against an aminoacycl transfer RNA synthetase (ARS) along with a group of clinical features including the classical clinical triad: inflammatory myopathy, arthritis, and interstitial lung disease (ILD). ASSD is highly heterogenous due to different organ involvement, and ILD is the main cause of mortality and function loss, which presents as different patterns when diagnosed. We designed this retrospective cohort to describe the clinical features and disease behaviour of ASSD associated ILD. MethodsData of 108 cases of ASSD associated ILD were retrospectively collected in Beijing Chaoyang Hospital from 2017.12 to 2019.3. Data were obtained from the Electronic Medical Record (EMR) system. Patients were divided into 5 groups according to distinct aminoacyl tRNA synthetase (ARS) antibodies. Results:Overall, 108 consecutive patients were recruited. 33 were JO-1 positive,30 were PL-7 positive,23 were EJ positive, 13 were PL12 positive and 9were OJ positive. The JO-1 group had a significant higher rate of mechanic’s hand (57.6%) than other 4 groups. Polymyositis/ dermatomyositis (PM/DM) was diagnosed in 25 (23.1%) patients and no difference was observed among the 5 groups. The anti-PL7 positive group had a higher frequency of UIP pattern (13.3%) than the other 4 groups but the difference was not significant, and the EJ group had the most frequent OP pattern(78.2%), which was significantly higher than the PL-7 (P<0.001) and PL-12 groups (P=0.025). The median follow-up time was 10.7 months, during which no patients died. All received prednisone treatment, with or without immunosuppressants. At the 6-month-follow up, 96.3% of all patients (104/108) had a positive response to therapy, the JO-1 and EJ groups had a significantly higher improvement of forced vital capacity than the other 3 groups (P<0.05), and the PL-7 group had the lowest FVC improvement (P<0.05). The anti-JO1-positive group and anti-EJ-positive group had significantly higher anti-RO52-positive occurrence than the other 3 groups (P<0.05).ConclusionAnti PL-7 antibody had the same frequency as anti-JO1 in ASSD-ILD, in which the ILD pattern was different with distinct anti-ARS antibodies. Most ASSD-ILD had a positive response to steroid therapies, with or without immunosuppressants. The PL-7 group had the highest occurrence of UIP pattern, and a significantly lower response to therapy.